Glenmede Trust’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-69,459	Closed	-$524K	–	1257
2023 Q2	$524K	Hold	69,459	–	–	﹤0.01%	814
2023 Q1	$524K	Buy	69,459 +774	+1%	+$5.84K	﹤0.01%	817
2022 Q4	$696K	Buy	+68,685	New	+$696K	﹤0.01%	746